Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Virtual

Jun 24, 2021 1:00 PM - Jun 24, 2021 4:00 PM

#042P: Compliance by Design: Blockchain in Clinical Research and Drug Development

Instructors

Wendy  Charles, PhD

Wendy Charles, PhD

Chief Ethics and Compliance Officer; Adjunct Faculty, Equideum Health, United States

Dr. Wendy Charles has been involved in clinical trials from every perspective for nearly 30 years with a strong background in operations and compliance of digital health technologies. She currently serves as Chief Scientific Officer for BurstIQ, a health IT company specializing in blockchain and AI. She is also an adjunct faculty member in the Health Administration program at the University of Colorado, Denver and in two departments at the University of Denver. Dr. Charles augments her blockchain healthcare experience by serving on the EU Blockchain Advisory Panel, Government Blockchain Association, and IEEE Standardization Committees. She is certified as an IRB Professional, Clinical Research Professional, and Blockchain Professional.

Sean  Manion, PhD

Sean Manion, PhD

Chief Scientific Officer and FNO Coordination Lead, Equideum Health, United States

Sean Manion, PhD is a neuroscientist with two decades of federal brain research and leadership experience. He is the Chief Scientific Officer of ConsenSys Health, a start-up focused on the application of emerging technology (blockchain, decentralized machine learning, and privacy-preserving encryption) in healthcare and life sciences. He completed his doctoral and post-doctoral work as a civilian at Uniformed Services University of the Health Sciences looking at pre-clinical models of post-traumatic stress disorder (1999-2009). He continued work with the Military Health System as Deputy Chief of Staff and later Research Activities Chief for the Defense and Veterans Brain Injury Center (2009-2017).

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.